# Constellation Brands, Inc.: overview

STZ · NYSE · CIK 16918 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Feb 28

Pages: [Overview](/companies/stz.md) · [Financials](/companies/stz/financials.md) · [Filings](/companies/stz/filings.md) · [Insiders](/companies/stz/insiders.md)

Latest reported revenue: [$2.63bn](/filings/0000016918-26-000040.md) for Q2 FY2027, three months to 2026-08-31, from the 10-Q filed Oct 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000016918-26-000040).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,464](/filings/0000016918-26-000005.md) | [2,164](/filings/0000016918-26-000011.md) | [2,515](/filings/0000016918-26-000029.md) | [2,481](/filings/0000016918-26-000040.md) | [2,223](/filings/0000016918-26-000005.md) | [1,920](/filings/0000016918-26-000011.md) | [2,433](/filings/0000016918-26-000029.md) | [2,633](/filings/0000016918-26-000040.md) |
| Gross margin | % | [52.1%](/filings/0000016918-26-000005.md) | [51.5%](/filings/0000016918-26-000011.md) | [50.4%](/filings/0000016918-26-000029.md) | [52.8%](/filings/0000016918-26-000040.md) | [53.2%](/filings/0000016918-26-000005.md) | [49.6%](/filings/0000016918-26-000011.md) | [54.3%](/filings/0000016918-26-000029.md) | [52.9%](/filings/0000016918-26-000040.md) |
| Operating margin | % | [32.2%](/filings/0000016918-26-000005.md) | [(6.9%) d](/filings/0000016918-26-000011.md) | [28.4%](/filings/0000016918-26-000029.md) | [35.2%](/filings/0000016918-26-000040.md) | [31.1%](/filings/0000016918-26-000005.md) | [23.0% d](/filings/0000016918-26-000011.md) | [34.7%](/filings/0000016918-26-000029.md) | [30.6%](/filings/0000016918-26-000040.md) |
| Net margin | % | [25.0%](/filings/0000016918-26-000005.md) | [(17.3%)](/filings/0000016918-26-000011.md) | [20.5%](/filings/0000016918-26-000029.md) | [18.8%](/filings/0000016918-26-000040.md) | [22.6%](/filings/0000016918-26-000005.md) | [10.5%](/filings/0000016918-26-000011.md) | [26.9%](/filings/0000016918-26-000029.md) | [21.5%](/filings/0000016918-26-000040.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $m | [457 d](/filings/0000016918-26-000005.md) | [312 d](/filings/0000016918-26-000011.md) | [444](/filings/0000016918-26-000029.md) | [635 d](/filings/0000016918-26-000040.md) | [371 d](/filings/0000016918-26-000005.md) | [344 d](/filings/0000016918-26-000011.md) | [485](/filings/0000016918-26-000029.md) | [640 d](/filings/0000016918-26-000040.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-02-28) | FY2023 (2023-02-28) | FY2024 (2024-02-29) | FY2025 (2025-02-28) | FY2026 (2026-02-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.8](/filings/0000016918-24-000054.md) | [9.5](/filings/0000016918-25-000022.md) | [10.0](/filings/0000016918-26-000011.md) | [10.2](/filings/0000016918-26-000011.md) | [9.1](/filings/0000016918-26-000011.md) |
| Gross margin | % | [53.4%](/filings/0000016918-24-000054.md) | [50.5%](/filings/0000016918-25-000022.md) | [50.4%](/filings/0000016918-26-000011.md) | [52.1%](/filings/0000016918-26-000011.md) | [51.6%](/filings/0000016918-26-000011.md) |
| Operating margin | % | [26.4%](/filings/0000016918-24-000054.md) | [30.1%](/filings/0000016918-25-000022.md) | [31.8%](/filings/0000016918-26-000011.md) | [3.5%](/filings/0000016918-26-000011.md) | [29.8%](/filings/0000016918-26-000011.md) |
| Net margin | % | [(0.5%)](/filings/0000016918-24-000054.md) | [(0.8%)](/filings/0000016918-25-000022.md) | [17.3%](/filings/0000016918-26-000011.md) | [(0.8%)](/filings/0000016918-26-000011.md) | [18.5%](/filings/0000016918-26-000011.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported |
| Free cash flow | $bn | [1.7](/filings/0000016918-24-000054.md) | [1.7](/filings/0000016918-25-000022.md) | [1.5](/filings/0000016918-26-000011.md) | [1.9](/filings/0000016918-26-000011.md) | [1.8](/filings/0000016918-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL not reported.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/stz/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.61bn | 11,539,924 |  | Added +420,325 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $1.56bn | 11,208,782 |  | Reduced −997,711 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.30bn | 9,337,443 |  | Added +261,427 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.09bn | 7,835,510 |  | Added +320,308 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $944.3m | 6,788,959 |  | Reduced −236,750 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $639.9m | 4,600,566 |  | Reduced −525,977 |
| [Grantham, Mayo, Van Otterloo & Co. LLC](/funds/1352662.md) | 2026-06-30 | $556.1m | 3,998,425 |  | Reduced −27,355 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $531.0m | 3,817,651 |  | Reduced −2,813,266 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $529.3m | 3,820,120 |  | Added +11,231 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $481.1m | 3,460,678 |  | Added +52,747 |

## Recent filings

[All 1,835 filings](/companies/stz/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 18:00 ET | [10-Q](/filings/0000016918-26-000040.md) | Quarterly report, period 2026-08-31 | 0000016918-26-000040 |
| 2026-10-06 | 20:18 ET | [8-K](/filings/0000016918-26-000039.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000016918-26-000039 |
| 2026-09-18 | 20:15 ET | [8-K](/filings/0001193125-26-395558.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-395558 |
| 2026-09-08 | 21:20 ET | [8-K](/filings/0000016918-26-000034.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000016918-26-000034 |
| 2026-07-24 | 20:15 ET | [8-K](/filings/0000016918-26-000032.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000016918-26-000032 |
| 2026-07-01 | 18:00 ET | [10-Q](/filings/0000016918-26-000029.md) | Quarterly report, period 2026-05-31 | 0000016918-26-000029 |
| 2026-06-30 | 20:08 ET | [8-K](/filings/0000016918-26-000028.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000016918-26-000028 |
| 2026-06-08 | 12:56 ET | [DEF 14A](/filings/0000016918-26-000023.md) | Proxy statement, period 2026-02-28 | 0000016918-26-000023 |
| 2026-05-21 | 11:34 ET | [8-K](/filings/0000016918-26-000016.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000016918-26-000016 |
| 2026-05-06 | 20:38 ET | [8-K](/filings/0001193125-26-209180.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-209180 |

## Latest annual report

[Form 10-K for the fiscal year ended Feb 28, 2026](/filings/0000016918-26-000011.md), filed Apr 22, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 16918
- Tickers: STZ
- Exchange: NYSE
- SIC code: 2080 Beverages
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.